From the Globe and Mail:
Canadian patients who were trying Pfizer Inc.'s new cholesterol treatment, torcetrapib, are being asked to stop immediately, the drug maker's Canadian arm told the Globe and Mail Monday.
The news comes after Pfizer said Saturday it had halted development of its key new cholesterol treatment. An independent board monitoring a study for torcetrapib recommended that the work end because of an unexpected number of deaths. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Tuesday, December 05, 2006
Pfizer stops Canadian trials
This is the first article I've seen mentioning a Canadian connection to torcetrapib. It shouldn't be a surprise that trials were being done here. There are many studies going on that are North America wide and essentially disregard the border.
No comments:
Post a Comment